Abstract
For the first time, a population approach was used to describe abacavir (ABC) pharmacokinetics in HIV-infected pregnant and nonpregnant women. A total of 266 samples from 150 women were obtained. No covariate effect (from age, body weight, pregnancy, or gestational age) on ABC pharmacokinetics was found. Thus, it seems unnecessary to adapt the ABC dosing regimen during pregnancy.Copyright
Cite
CITATION STYLE
Fauchet, F., Treluyer, J. M., Préta, L. H., Valade, E., Pannier, E., Urien, S., & Hirt, D. (2014). Population pharmacokinetics of abacavir in pregnant women. Antimicrobial Agents and Chemotherapy, 58(10), 6287–6289. https://doi.org/10.1128/AAC.03469-14
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.